1. Albin R, Greenamyre J: Alternative excitotoxin hypotheses. Neurology 42:733-738, 1992

*2. Buchan A, Pulsinelli WA: Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia. J Neurosci 10:311-316, 1990

3. Buchan A, Li H, Cho S, Pulsinelli W: Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult rats. Neurosci Lett 132:255-258, 1991

4. Buchan A, Li H, Pulsinelli WA: The N-methyl-D-aspartate antagonist, MK-801, fails to protect against neuronal damage caused by transient, severe forebrain ischemia in adult rats. J Neurosci 11:1049-1056, 1991

5. Buchan A, Xue D, Huang Z, Smith K, Lesiuk H: Delayed AMPA receptor blockade reduces cerebral infarction induced by focal ischemia. Neuroreport 2:473-476, 1991

*6. Buchan AM, Lesiuk H, Barnes KA, Li H, Huang Z-G, Smithe KE, Xue D: AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists? Stroke 24(Suppl I) :I-148-I-152, 1993

+7. Choi D: Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634, 1988

8. Choi DW: Methods for antagonizing glutamate neurotoxicity. Cerebrovasc Brain Met Rev 2:105-147, 1990

9. Church J, Zeman S, Lodge O: The neuroprotective effect of ketamine and MK-801 after transient cerebral ischemia in rats. Anesthesiology 69:702-709, 1988

10. Fossom LH, Von Lubitz DKJE, Lin RC-S, Skolnick P: Neuroprotective actions of 1-aminocyclopropanecarboxylic acid (ACPC): a partial agonist at strychnine-insensitive glycine sites. Neurol Res 17:265-269, 1995

11. Giffard RG, Monyer H, Christine CW, Choi DW: Acidosis reduces NMDA receptor activation, glutamate neurotoxicity, and oxygen-glucose deprivation neuronal injury in cortical cultures. Brain Res 506:339-342, 1990

12. Kendall TJ, Minchin MC: The effects of anaesthetics on the uptake and release of amino acid neurotransmitters in thalamic slices. Br J Pharm 75:219-227, 1982

13. Koh JY, Palmer E, Cotman CW: Activation of the metabotropic glutamate receptor attenuates N-methyl-D-aspartate neurotoxicity in cortical cultures. Proc Natl Acad Sci USA 88:9431-9435, 1991

14. Lanier WL, Perkins WJ, Karisson BR, Milde JH, Scheithauer BW, Shearman GT, Michenfelder JD: The effects of dizocilipine maleate [MK-801], an antagonist of the N-methyl-D-aspartate receptor, on neurologic recovery and histopathology following complete cerebral ischemia in primates. J Cereb Blood Flow Metab 10:252-261, 1990

*15. Lodge D, Johnson KM: Noncompetitive excitatory amino acid receptor antagonists. Trends Pharmacol Sci 11:81-86, 1990

16. Meldrum BS: Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission. Cerebrovasc Brain Met Rev 2:27-57, 1990

*17. Murray CW, Cowan A, Larson AA: Neurokinin and NMDA antagonists (but not a kainic acid antagonist) are antinociceptive in the mouse formalin model. Pain 44:179-185, 1991

18. Nellgard B, Wieloch T: Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia. J Cereb Blood Flow Metab 12:2-11, 1992

19. Nicoll R: The coupling of neurotransmitter receptors to ion channels in the brain. Science 241:545-551, 1988

20. Olney JW, Price MT, Fuller TA, Labruyere J, Samson L, Carpenter M, Mahan K: The anti-excitotoxic effects of certain anesthetic analgesics, and sedative-hypnotics. Neurosci Lett 68:29-34, 1986

21. Olney J, Labruyere J, Wang G, Wozniak D, Price M, Sesma M: NMDA antagonist neurotoxicity: Mechanism and prevention. Science 254:1515-1518, 1991

22. Onodera H, Araki T, Kogure K: Excitatory amino acid binding sites in the rat hippocampus after transient forebrain ischemia. J Cereb Blood Flow Metab 9:623-628, 1989

23. Ozyurt E, Graham DI, Woodruff GN, McCulloch J: Protective effect of the glutamate antagonist, MK-801, in focal cerebral ischemia in the cat. J Cereb Blood Flow Metab 8:138-143, 1988

24. Perkins WJ, Lanier WL, Karlsson BR, Milde JH, Michenfelder JD: The effect of the excitatory amino acid receptor antagonist dizocilipine maleate [MK-801] on hemispheric cerebral blood flow and metabolism in dogs: Modification by prior complete cerebral ischemia. Brain Res 498:34-44, 1989

25. Rothman SM: Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death. J Neurosci 4:1884-1891, 1984

26. Sheardown MJ, Nielsen EO, Hansen AJ, Jacobsen P, Honore T: 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. Science 247:571-574, 1990

*27. Sheardown MJ: The pharmacology of AMPA receptors and their antagonists. Stroke 24 (Suppl I):I-146-I-147, 1993

28. Steinberg GK, Kunis D, Saleh J, DeLaPaz R: Protection after transient focal cerebral ischemia by the N-methyl-D-aspartate antagonist dextrorphan is dependent upon plasma and brain levels. J Cereb Blood Flow Metab 11:1015-1524, 1991

29. Sterz F, Leonov Y, Safar P, Radovsky A, Stezoski SW, Reich H, Shearman GT, Greber TF: Effect of excitatory amino acid receptor blocker MK 801 on overall, neurologic, and morphologic outcome after prolonged cardiac arrest in dogs. Anesthesiology 71:907-918, 1989

30. Thompson SWN, King AE, Woolf CJ: Activity-dependent changes in rat ventral neurones in vitro: summation of prolonged postsynaptic depolarizations produce d-APV sensitive windup. Eur J Neurosci 2:638-649, 1990

31. Trujillo KA, Akil H: Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251:85-87, 1991

32. Wieloch T: Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist. Science 230:681-683, 1985

33. Woolf CJ, Thompson SW: The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain 44:293-299, 1991